Karessa's licence reinforced through patent granted in South Korea

A recently granted patent in South Korea has reinforced Karessa's licence in the field of erectile dysfunction. This entails recognition of Karessa's technical platform as well as sole rights to the company's products on the large and growing South Korean market.Karessa's solution comprises a unique concept, combining the company's patented drug delivery platform with clinically tested and proven substances (e.g. Sildenafil and Tadalafil). This combination is creating major patient benefits in the form of fast and reliable effects. With the approval from the South Korean patent office, the